|
Re: Herceptin (Trastuzumab) for Breast Cancer Linked to CNS Metastases
I know what you mean about undiagnosed brain mets. I think sometimes clinical trial information can be off because "NED" patients enroll, then have metatasis. Honestly the met was there before the trial, but scanning is too expensive and therefore the mets go undiscovered.
I am interested in the newer treatments such as Kadcyla, Tykerb and Pertuzamaub and the recurrence of brain mets. It looks like the expectation is CNS mets will decrease.
I am also curious to see the statistics from the vaccine trials and the types of mets.
__________________
Diagnosed 2007
Stage IIb Invasive Ductal Carcinoma, Pagets, 3 of 15 positive nodes
Traditional Treatment: Mastectomy and Axillary Node Dissection followed by Taxotere, 6 treatments and 1 year of Herceptin, no radiation
Former Chemo Ninja "Takizi Zukuchiri"
Additional treatments:
GP2 vaccine, San Antonio Med Ctr
Prescriptive Exercise for Cancer Patients
ENERGY Study, UCSD La Jolla
Reconstruction: TRAM flap, partial loss, Revision
The content of my posts are meant for informational purposes only. The medical information is intended for general information only and should not be used in any way to diagnose, treat, cure, or prevent disease
|